The shortages are really, really bad right now, Dr
Author Contributions Concept and design: Chebly Dagher, Maria Akiki, Evan Nadler Acquisition, analysis, or interpretation of data: Chebly Dagher, Mohamed Jailani, Maria Akiki, Talha Siddique, Zidan Saleh, Evan Nadler Drafting of the manuscript: Chebly Dagher, Mohamed Jailani, Maria Akiki, Evan Nadler Critical review of the manuscript for important intellectual content: Chebly Dagher, Mohamed Jailani, Maria Akiki, Talha Siddique, Zidan Saleh, Evan Nadler Supervision: Mohamed Jailani, Maria Akiki, Talha Siddique, Evan Nadler References 1.Glucagon-like peptide 1 (GLP-1): a potent gut hormone with a possible therapeutic perspective
By directly targeting the bacteria with ozone therapy and supporting the body with essential nutrients, IV therapy can help reduce symptoms and improve quality of life for those suffering from chronic Lyme
Whilst RCTs have reported DKA ranging from 0.84.3% [34], real-world rates of DKA have ranged from 0.0 [38]3.5% [25] with one outlier of 12.5% [14]